Fresenius Medical Care AG & Co. KGaA (FMEd)

Fresenius Medical Care beat expectations on earnings while revenue was roughly in line in the second fiscal quarter of 2026, reported August 3, 2026, with adjusted EPS of EUR 1.11 topping the EUR 1.06 estimate (+4.7%) as revenue of EUR 4.861 billion came in line with the EUR 4.788 billion consensus (+1.5%). Revenue rose ~1% year over year to about EUR 4.9 billion from roughly EUR 4.8 billion a year ago, while net income slipped ~3% to about EUR 218 million versus roughly EUR 225 million. Profitability included gross profit of about EUR 1.3 billion, translating to a gross margin near 27%, and operating income of roughly EUR 534 million with an operating margin around 11%. Operating cash flow was about EUR 860 million for the quarter. Year over year, adjusted EPS increased ~21% to EUR 1.11 from EUR 0.92. For the next period, consensus calls for EPS of EUR 1.05 on revenue of EUR 4.939 billion.